WallStreetZenWallStreetZen

NASDAQ: TEM
Tempus Ai Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TEM

Based on 8 analysts offering 12 month price targets for Tempus Ai Inc

Min Forecast
$80.00+28.29%
Avg Forecast
$89.25+43.12%
Max Forecast
$105.00+68.38%

Should I buy or sell TEM stock?

Based on 8 analysts offering ratings for Tempus Ai Inc.

Strong Buy
Strong Buy
4 analysts 50%
Buy
2 analysts 25%
Hold
2 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TEM's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates TEM as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their TEM stock forecasts and price targets.

TEM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-22
lockedlocked$00.00+00.00%2025-12-15
lockedlocked$00.00+00.00%2025-12-02
lockedlocked$00.00+00.00%2025-11-25Find Out Why
lockedlocked$00.00+00.00%2025-11-11
HC Wainwright & Co.
Top 22%
79
BuyMaintains$89.00+42.72%2025-11-07
Needham
Bottom 2%
2
BuyMaintains$100.00+60.36%2025-11-05
Guggenheim
Top 11%
90
Strong BuyMaintains$95.00+52.34%2025-09-26Find out why

1 of 1

Forecast return on equity

Is TEM forecast to generate an efficient return?

Company
12.68%
Industry
14.52%
Market
341.8%
TEM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TEM forecast to generate an efficient return on assets?

Company
2.82%
Industry
13.38%
TEM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TEM earnings per share forecast

What is TEM's earnings per share in the next 2 years based on estimates from 17 analysts?

Avg 1 year Forecast
-$0.40
Avg 2 year Forecast
$0.36

TEM revenue forecast

What is TEM's revenue in the next 2 years based on estimates from 17 analysts?

Avg 1 year Forecast
$1.6B+43.68%
Avg 2 year Forecast
$1.9B+71.63%
TEM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TEM revenue growth forecast

How is TEM forecast to perform vs Health Information Services companies and vs the US market?

Company
43.68%
Industry
14.23%
Market
1,473.52%
TEM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TEM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TEM vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
TEM$62.36$89.25+43.12%Strong Buy
SOLV$79.02$90.33+14.32%Buy
DOCS$43.29$67.80+56.62%Buy
HQY$91.07$120.00+31.77%Strong Buy
BTSG$38.40$41.67+8.51%Strong Buy
View Top Health Information Service Stocks

Tempus Ai Stock Forecast FAQ

Is Tempus Ai Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: TEM) stock is to Strong Buy TEM stock.

Out of 8 analysts, 4 (50%) are recommending TEM as a Strong Buy, 2 (25%) are recommending TEM as a Buy, 2 (25%) are recommending TEM as a Hold, 0 (0%) are recommending TEM as a Sell, and 0 (0%) are recommending TEM as a Strong Sell.

If you're new to stock investing, here's how to buy Tempus Ai stock.

What is TEM's earnings growth forecast for 2026-2027?

(NASDAQ: TEM) Tempus Ai's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 94.18%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,166.94%.

Tempus Ai's earnings in 2026 is -$203,876,000.On average, 17 Wall Street analysts forecast TEM's earnings for 2026 to be -$70,433,484, with the lowest TEM earnings forecast at -$364,389,648, and the highest TEM earnings forecast at $5,604,079.

In 2027, TEM is forecast to generate $64,384,637 in earnings, with the lowest earnings forecast at -$15,691,420 and the highest earnings forecast at $153,178,150.

What is TEM's revenue growth forecast for 2026-2027?

(NASDAQ: TEM) Tempus Ai's forecast annual revenue growth rate of 43.68% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 14.23%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,473.52%.

Tempus Ai's revenue in 2026 is $1,105,258,000.On average, 17 Wall Street analysts forecast TEM's revenue for 2026 to be $282,516,727,292, with the lowest TEM revenue forecast at $269,173,682,867, and the highest TEM revenue forecast at $303,687,691,113.

In 2027, TEM is forecast to generate $337,490,070,323 in revenue, with the lowest revenue forecast at $254,407,380,370 and the highest revenue forecast at $369,335,469,684.

What is TEM's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: TEM) forecast ROA is 2.82%, which is lower than the forecast US Health Information Services industry average of 13.38%.

What is TEM's Price Target?

According to 8 Wall Street analysts that have issued a 1 year TEM price target, the average TEM price target is $89.25, with the highest TEM stock price forecast at $105.00 and the lowest TEM stock price forecast at $80.00.

On average, Wall Street analysts predict that Tempus Ai's share price could reach $89.25 by Dec 22, 2026. The average Tempus Ai stock price prediction forecasts a potential upside of 43.12% from the current TEM share price of $62.36.

What is TEM's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: TEM) Tempus Ai's current Earnings Per Share (EPS) is -$0.30. On average, analysts forecast that TEM's EPS will be -$0.40 for 2026, with the lowest EPS forecast at -$2.05, and the highest EPS forecast at $0.03. In 2027, TEM's EPS is forecast to hit $0.36 (min: -$0.09, max: $0.86).

What is TEM's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: TEM) forecast ROE is 12.68%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.